{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T05:38:10Z","timestamp":1775885890695,"version":"3.50.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhejiang Provincial Traditional Chinese Medicine Science and Technology Project.","award":["2024ZL181"],"award-info":[{"award-number":["2024ZL181"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-19177-2","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T18:41:48Z","timestamp":1759171308000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association between cardiometabolic index and cardiometabolic multimorbidity in non-alcoholic fatty liver disease patients: evidence from a cross-sectional study"],"prefix":"10.1038","volume":"15","author":[{"given":"Jiayuan","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilian","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuejiang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"19177_CR1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/s2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi, K. et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 7, 851\u2013861. https:\/\/doi.org\/10.1016\/s2468-1253(22)00165-0 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"19177_CR2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.atherosclerosis.2019.01.029","volume":"282","author":"RD Santos","year":"2019","unstructured":"Santos, R. D., Valenti, L. & Romeo, S. Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps. Atherosclerosis 282, 110\u2013120. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.01.029 (2019).","journal-title":"Atherosclerosis"},{"key":"19177_CR3","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M. & Sanyal, A. J. Mechanisms of NAFLD development and therapeutic strategies. Nat. Med. 24, 908\u2013922. https:\/\/doi.org\/10.1038\/s41591-018-0104-9 (2018).","journal-title":"Nat. Med."},{"key":"19177_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatol. (Baltimore Md). 64, 73\u201384. https:\/\/doi.org\/10.1002\/hep.28431 (2016).","journal-title":"Hepatol. (Baltimore Md)"},{"key":"19177_CR5","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1093\/eurjpc\/zwab212","volume":"29","author":"L Alon","year":"2022","unstructured":"Alon, L. et al. Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis. Eur. J. Prev. Cardiol. 29, 938\u2013946. https:\/\/doi.org\/10.1093\/eurjpc\/zwab212 (2022).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"19177_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne, C. D. & Targher, G. NAFLD: a multisystem disease. J. Hepatol. 62, 47\u201364. https:\/\/doi.org\/10.1016\/j.jhep.2014.12.012 (2015).","journal-title":"J. Hepatol."},{"key":"19177_CR7","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1161\/atvbaha.114.305200","volume":"35","author":"MT Long","year":"2015","unstructured":"Long, M. T. et al. Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study. Arterioscler. Thromb. Vasc. Biol. 35, 1284\u20131291. https:\/\/doi.org\/10.1161\/atvbaha.114.305200 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"19177_CR8","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.jhep.2014.11.034","volume":"62","author":"S McPherson","year":"2015","unstructured":"McPherson, S. et al. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. J. Hepatol. 62, 1148\u20131155. https:\/\/doi.org\/10.1016\/j.jhep.2014.11.034 (2015).","journal-title":"J. Hepatol."},{"key":"19177_CR9","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","volume":"66","author":"LA Adams","year":"2017","unstructured":"Adams, L. A., Anstee, Q. M., Tilg, H. & Targher, G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut 66, 1138\u20131153. https:\/\/doi.org\/10.1136\/gutjnl-2017-313884 (2017).","journal-title":"Gut"},{"key":"19177_CR10","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.1161\/strokeaha.115.008097","volume":"46","author":"S Mendis","year":"2015","unstructured":"Mendis, S., Davis, S. & Norrving, B. Organizational update: the world health organization global status report on noncommunicable diseases 2014; one more landmark step in the combat against stroke and vascular disease. Stroke 46, e121\u2013122. https:\/\/doi.org\/10.1161\/strokeaha.115.008097 (2015).","journal-title":"Stroke"},{"key":"19177_CR11","doi-asserted-by":"publisher","first-page":"430","DOI":"10.4093\/dmj.2017.41.6.430","volume":"41","author":"E Han","year":"2017","unstructured":"Han, E. & Lee, Y. H. Non-Alcoholic fatty liver disease: the emerging burden in cardiometabolic and renal diseases. Diabetes Metabolism J. 41, 430\u2013437. https:\/\/doi.org\/10.4093\/dmj.2017.41.6.430 (2017).","journal-title":"Diabetes Metabolism J."},{"key":"19177_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1001\/jama.2015.7008","volume":"314","author":"E Di Angelantonio","year":"2015","unstructured":"Di Angelantonio, E. et al. Association of cardiometabolic Multimorbidity with mortality. Jama 314, 52\u201360. https:\/\/doi.org\/10.1001\/jama.2015.7008 (2015).","journal-title":"Jama"},{"key":"19177_CR13","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cca.2014.08.042","volume":"438","author":"I Wakabayashi","year":"2015","unstructured":"Wakabayashi, I. & Daimon, T. The cardiometabolic index as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitus. Clin. Chim. Acta. 438, 274\u2013278. https:\/\/doi.org\/10.1016\/j.cca.2014.08.042 (2015).","journal-title":"Clin. Chim. Acta"},{"key":"19177_CR14","doi-asserted-by":"publisher","first-page":"8224","DOI":"10.1038\/s41598-021-87266-z","volume":"11","author":"K Lechner","year":"2021","unstructured":"Lechner, K., Lechner, B., Crispin, A., Schwarz, P. E. H. & von Bibra, H. Waist-to-height ratio and metabolic phenotype compared to the Matsuda index for the prediction of insulin resistance. Sci. Rep. 11, 8224. https:\/\/doi.org\/10.1038\/s41598-021-87266-z (2021).","journal-title":"Sci. Rep."},{"key":"19177_CR15","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12944-019-1123-3","volume":"18","author":"WC Yeh","year":"2019","unstructured":"Yeh, W. C. et al. Elevated triglyceride-to-HDL cholesterol ratio is an indicator for insulin resistance in middle-aged and elderly Taiwanese population: a cross-sectional study. Lipids Health Dis. 18, 176. https:\/\/doi.org\/10.1186\/s12944-019-1123-3 (2019).","journal-title":"Lipids Health Dis."},{"key":"19177_CR16","doi-asserted-by":"publisher","first-page":"1448359","DOI":"10.3389\/fendo.2024.1448359","volume":"15","author":"W Huang","year":"2024","unstructured":"Huang, W., Wang, H., Shen, Z., Wang, X. & Yu, X. Association between TyG index and risk of carotid atherosclerosis in NAFLD patients: a retrospective cohort study. Front. Endocrinol. 15, 1448359. https:\/\/doi.org\/10.3389\/fendo.2024.1448359 (2024).","journal-title":"Front. Endocrinol."},{"key":"19177_CR17","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1172\/jci134165","volume":"130","author":"GI Smith","year":"2020","unstructured":"Smith, G. I. et al. Insulin resistance drives hepatic de Novo lipogenesis in nonalcoholic fatty liver disease. J. Clin. Investig. 130, 1453\u20131460. https:\/\/doi.org\/10.1172\/jci134165 (2020).","journal-title":"J. Clin. Investig."},{"key":"19177_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12933-022-01456-1","volume":"21","author":"H Cui","year":"2022","unstructured":"Cui, H., Liu, Q., Wu, Y. & Cao, L. Cumulative triglyceride-glucose index is a risk for CVD: a prospective cohort study. Cardiovasc. Diabetol. 21, 22. https:\/\/doi.org\/10.1186\/s12933-022-01456-1 (2022).","journal-title":"Cardiovasc. Diabetol."},{"key":"19177_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12944-024-02027-x","volume":"23","author":"WF Xi","year":"2024","unstructured":"Xi, W. F. & Yang, A. M. Association between cardiometabolic index and controlled Attenuation parameter in U.S. Adults with NAFLD: findings from NHANES (2017\u20132020). Lipids Health Dis. 23, 40. https:\/\/doi.org\/10.1186\/s12944-024-02027-x (2024).","journal-title":"Lipids Health Dis."},{"key":"19177_CR20","doi-asserted-by":"publisher","unstructured":"Zou, J. et al. Association between the cardiometabolic index and non-alcoholic fatty liver disease: insights from a general population. BMC Gastroenterol. 22 https:\/\/doi.org\/10.1186\/s12876-022-02099-y (2022).","DOI":"10.1186\/s12876-022-02099-y"},{"key":"19177_CR21","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1007\/s10067-018-4143-x","volume":"37","author":"H Wang","year":"2018","unstructured":"Wang, H. et al. Body adiposity index, lipid accumulation product, and cardiometabolic index reveal the contribution of adiposity phenotypes in the risk of hyperuricemia among Chinese rural population. Clin. Rheumatol. 37, 2221\u20132231. https:\/\/doi.org\/10.1007\/s10067-018-4143-x (2018).","journal-title":"Clin. Rheumatol."},{"key":"19177_CR22","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41430-019-0413-1","volume":"73","author":"M Mazidi","year":"2019","unstructured":"Mazidi, M., Huybrechts, I. & Kengne, A. P. Associations between serum lipophilic antioxidants levels and non-alcoholic fatty liver disease are moderated by adiposity. Eur. J. Clin. Nutr. 73, 1088\u20131090. https:\/\/doi.org\/10.1038\/s41430-019-0413-1 (2019).","journal-title":"Eur. J. Clin. Nutr."},{"key":"19177_CR23","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1039\/d2fo02204d","volume":"14","author":"K Zhang","year":"2023","unstructured":"Zhang, K. et al. The association between serum vitamin A and NAFLD among US adults varied in different BMI groups: a cross-sectional study. Food Funct. 14, 836\u2013844. https:\/\/doi.org\/10.1039\/d2fo02204d (2023).","journal-title":"Food Funct."},{"key":"19177_CR24","doi-asserted-by":"publisher","first-page":"116556","DOI":"10.1016\/j.ecoenv.2024.116556","volume":"280","author":"A Zhang","year":"2024","unstructured":"Zhang, A. et al. Associations of serum lead, cadmium, and mercury concentrations with all-cause and cause-specific mortality among individuals with cardiometabolic Multimorbidity. Ecotoxicol. Environ. Saf. 280, 116556. https:\/\/doi.org\/10.1016\/j.ecoenv.2024.116556 (2024).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"19177_CR25","doi-asserted-by":"publisher","first-page":"116873","DOI":"10.1016\/j.envres.2023.116873","volume":"237","author":"Z Jiang","year":"2023","unstructured":"Jiang, Z. et al. Long-term influence of air pollutants on morbidity and all-cause mortality of cardiometabolic multi-morbidity: A cohort analysis of the UK biobank participants. Environ. Res. 237, 116873. https:\/\/doi.org\/10.1016\/j.envres.2023.116873 (2023).","journal-title":"Environ. Res."},{"key":"19177_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jama.2021.9883","volume":"326","author":"L Wang","year":"2021","unstructured":"Wang, L. et al. Trends in prevalence of diabetes and control of risk factors in diabetes among US adults, 1999\u20132018. Jama 326, 1\u201313. https:\/\/doi.org\/10.1001\/jama.2021.9883 (2021).","journal-title":"Jama"},{"key":"19177_CR27","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/s41440-023-01195-0","volume":"46","author":"JP Xu","year":"2023","unstructured":"Xu, J. P. et al. Systemic inflammation markers and the prevalence of hypertension: A NHANES cross-sectional study. Hypertens. Re. Offi. J. Jpn. Soc. Hypertens. 46, 1009\u20131019. https:\/\/doi.org\/10.1038\/s41440-023-01195-0 (2023).","journal-title":"Hypertens. Res. Off. J. Jpn. Soc. Hypertens."},{"issue":"Suppl 3","key":"19177_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/ep161365.gl","volume":"22","author":"WT Garvey","year":"2016","unstructured":"Garvey, W. T. et al. American association of clinical endocrinologists and American college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr. Pract. 22 (Suppl 3), 1\u2013203. https:\/\/doi.org\/10.4158\/ep161365.gl (2016).","journal-title":"Endocr. Pract."},{"key":"19177_CR29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/hep4.1803","volume":"6","author":"P Rattan","year":"2022","unstructured":"Rattan, P. et al. Inverse association of telomere length with liver disease and mortality in the US population. Hepatol. Commun. 6, 399\u2013410. https:\/\/doi.org\/10.1002\/hep4.1803 (2022).","journal-title":"Hepatol. Commun."},{"key":"19177_CR30","doi-asserted-by":"publisher","first-page":"e1438","DOI":"10.1016\/j.cgh.2021.06.029","volume":"20","author":"D Kim","year":"2022","unstructured":"Kim, D., Konyn, P., Cholankeril, G. & Ahmed, A. Physical activity is associated with nonalcoholic fatty liver disease and significant fibrosis measured by fibroscan. Clin. Gastroenterol. Hepatology: Official Clin. Pract. J. Am. Gastroenterological Association. 20, e1438\u2013e1455. https:\/\/doi.org\/10.1016\/j.cgh.2021.06.029 (2022).","journal-title":"Clin. Gastroenterol. Hepatology: Official Clin. Pract. J. Am. Gastroenterological Association"},{"key":"19177_CR31","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP)","year":"2001","unstructured":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III). Jama 285, 2486\u20132497. https:\/\/doi.org\/10.1001\/jama.285.19.2486 (2001).","journal-title":"Jama"},{"key":"19177_CR32","first-page":"1","volume":"2","author":"CL Johnson","year":"2013","unstructured":"Johnson, C. L. et al. National health and nutrition examination survey: analytic guidelines, 1999\u20132010. Vital Health Stat. 2, 1\u201324 (2013).","journal-title":"Vital Health Stat."},{"key":"19177_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/apt.13012","volume":"41","author":"CE Ruhl","year":"2015","unstructured":"Ruhl, C. E. & Everhart, J. E. Fatty liver indices in the multiethnic united States National health and nutrition examination survey. Aliment. Pharmacol. Ther. 41, 65\u201376. https:\/\/doi.org\/10.1111\/apt.13012 (2015).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"19177_CR34","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/apt.17308","volume":"57","author":"A Henry","year":"2023","unstructured":"Henry, A. et al. Vigorous physical activity provides protection against all-cause deaths among adults patients with nonalcoholic fatty liver disease (NAFLD). Aliment. Pharmacol. Ther. 57, 709\u2013722. https:\/\/doi.org\/10.1111\/apt.17308 (2023).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"19177_CR35","doi-asserted-by":"publisher","first-page":"112295","DOI":"10.1016\/j.ecoenv.2021.112295","volume":"218","author":"C Chen","year":"2021","unstructured":"Chen, C. et al. Copper exposure association with prevalence of non-alcoholic fatty liver disease and insulin resistance among US adults (NHANES 2011\u20132014). Ecotoxicol. Environ. Saf. 218, 112295. https:\/\/doi.org\/10.1016\/j.ecoenv.2021.112295 (2021).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"19177_CR36","doi-asserted-by":"publisher","unstructured":"Tsou, P., Wu, C. J. & Serum Vitamin, E. Levels of adults with nonalcoholic fatty liver disease: an inverse relationship with All-Cause mortality in Non-Diabetic but not in Pre-Diabetic or diabetic subjects. J. Clin. Med. 8 https:\/\/doi.org\/10.3390\/jcm8071057 (2019).","DOI":"10.3390\/jcm8071057"},{"key":"19177_CR37","doi-asserted-by":"publisher","unstructured":"Li, J. et al. Visceral adiposity index is associated with arterial stiffness in hypertensive adults with normal-weight: the China H-type hypertension registry study. Nutr. Metabolism. 18 https:\/\/doi.org\/10.1186\/s12986-021-00617-5 (2021).","DOI":"10.1186\/s12986-021-00617-5"},{"key":"19177_CR38","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/cen.14564","volume":"96","author":"Z Guo","year":"2022","unstructured":"Guo, Z. et al. Free thyroxine, brain frailty and clock drawing test performance in patients with acute minor stroke or transient ischaemic attack. Clin. Endocrinol. 96, 175\u2013183. https:\/\/doi.org\/10.1111\/cen.14564 (2022).","journal-title":"Clin. Endocrinol."},{"key":"19177_CR39","doi-asserted-by":"publisher","unstructured":"Feng, X. et al. Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics. Theranostics 9, 1923\u20131951, (2019). https:\/\/doi.org\/10.7150\/thno.30787","DOI":"10.7150\/thno.30787"},{"key":"19177_CR40","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1186\/s12889-019-7682-4","volume":"19","author":"BM Sakakibara","year":"2019","unstructured":"Sakakibara, B. M., Obembe, A. O. & Eng, J. J. The prevalence of cardiometabolic Multimorbidity and its association with physical activity, diet, and stress in canada: evidence from a population-based cross-sectional study. BMC Public. Health. 19, 1361. https:\/\/doi.org\/10.1186\/s12889-019-7682-4 (2019).","journal-title":"BMC Public. Health"},{"key":"19177_CR41","doi-asserted-by":"publisher","unstructured":"Jani, B. D. et al. Relationship between multimorbidity, demographic factors and mortality: findings from the UK biobank cohort. BMC Med. 17 https:\/\/doi.org\/10.1186\/s12916-019-1305-x (2019).","DOI":"10.1186\/s12916-019-1305-x"},{"key":"19177_CR42","doi-asserted-by":"publisher","first-page":"1387374","DOI":"10.3389\/fendo.2024.1387374","volume":"15","author":"L He","year":"2024","unstructured":"He, L. et al. Correlation of cardiometabolic index and sarcopenia with cardiometabolic Multimorbidity in middle-aged and older adult: a prospective study. Front. Endocrinol. 15, 1387374. https:\/\/doi.org\/10.3389\/fendo.2024.1387374 (2024).","journal-title":"Front. Endocrinol."},{"key":"19177_CR43","doi-asserted-by":"publisher","first-page":"1302296","DOI":"10.3389\/fendo.2024.1302296","volume":"15","author":"T Dong","year":"2024","unstructured":"Dong, T. et al. Association of adiposity indicators with cardiometabolic Multimorbidity risk in hypertensive patients: a large cross-sectional study. Front. Endocrinol. 15, 1302296. https:\/\/doi.org\/10.3389\/fendo.2024.1302296 (2024).","journal-title":"Front. Endocrinol."},{"key":"19177_CR44","doi-asserted-by":"publisher","unstructured":"He, J. et al. The TG\/HDL-C Ratio Might Be a Surrogate for Insulin Resistance in Chinese Nonobese Women. Int. J. Endocrinol. 105168. https:\/\/doi.org\/10.1155\/2014\/105168 (2014).","DOI":"10.1155\/2014\/105168"},{"key":"19177_CR45","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1186\/s12876-021-02072-1","volume":"21","author":"J Wang","year":"2021","unstructured":"Wang, J. et al. Comparison of several blood lipid-related indexes in the screening of non-alcoholic fatty liver disease in women: a cross-sectional study in the Pearl river delta region of Southern China. BMC Gastroenterol. 21, 482. https:\/\/doi.org\/10.1186\/s12876-021-02072-1 (2021).","journal-title":"BMC Gastroenterol."},{"key":"19177_CR46","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1080\/00325481.2017.1375714","volume":"129","author":"H Wang","year":"2017","unstructured":"Wang, H., Chen, Y., Guo, X., Chang, Y. & Sun, Y. Usefulness of cardiometabolic index for the Estimation of ischemic stroke risk among general population in rural China. Postgrad. Med. 129, 834\u2013841. https:\/\/doi.org\/10.1080\/00325481.2017.1375714 (2017).","journal-title":"Postgrad. Med."},{"key":"19177_CR47","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/00325481.2018.1444901","volume":"130","author":"H Wang","year":"2018","unstructured":"Wang, H. et al. Validity of cardiometabolic index, lipid accumulation product, and body adiposity index in predicting the risk of hypertension in Chinese population. Postgrad. Med. 130, 325\u2013333. https:\/\/doi.org\/10.1080\/00325481.2018.1444901 (2018).","journal-title":"Postgrad. Med."},{"key":"19177_CR48","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000494908","volume":"53","author":"R Pasquali","year":"2019","unstructured":"Pasquali, R. & Oriolo, C. Obesity and androgens in women. Front. Horm. Res. 53, 120\u2013134. https:\/\/doi.org\/10.1159\/000494908 (2019).","journal-title":"Front. Horm. Res."},{"key":"19177_CR49","doi-asserted-by":"publisher","unstructured":"Meredith-Jones, K. et al. Age- and sex-specific visceral fat reference cutoffs and their association with cardio-metabolic risk. Int. J. Obes. 45, 808\u2013817. https:\/\/doi.org\/10.1038\/s41366-021-00743-3 (2021).","DOI":"10.1038\/s41366-021-00743-3"},{"key":"19177_CR50","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1007\/s12072-021-10209-3","volume":"15","author":"JH Park","year":"2021","unstructured":"Park, J. H., Koo, B. K., Kim, W. & Kim, W. H. Histological severity of nonalcoholic fatty liver disease is associated with 10-year risk for atherosclerotic cardiovascular disease. Hep. Intl. 15, 1148\u20131159. https:\/\/doi.org\/10.1007\/s12072-021-10209-3 (2021).","journal-title":"Hep. Intl."},{"key":"19177_CR51","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1016\/j.cgh.2021.09.021","volume":"20","author":"JZK Toh","year":"2022","unstructured":"Toh, J. Z. K. et al. A Meta-Analysis on the global prevalence, risk factors and screening of coronary heart disease in nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatology: Official Clin. Pract. J. Am. Gastroenterological Association. 20, 2462\u20132473e2410. https:\/\/doi.org\/10.1016\/j.cgh.2021.09.021 (2022).","journal-title":"Clin. Gastroenterol. Hepatology: Official Clin. Pract. J. Am. Gastroenterological Association"},{"key":"19177_CR52","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s12933-022-01697-0","volume":"21","author":"XD Zhou","year":"2022","unstructured":"Zhou, X. D. et al. Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention. Cardiovasc. Diabetol. 21, 270. https:\/\/doi.org\/10.1186\/s12933-022-01697-0 (2022).","journal-title":"Cardiovasc. Diabetol."},{"key":"19177_CR53","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.atherosclerosis.2013.01.022","volume":"227","author":"AP DeFilippis","year":"2013","unstructured":"DeFilippis, A. P. et al. Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic study of atherosclerosis. Atherosclerosis 227, 429\u2013436. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.01.022 (2013).","journal-title":"Atherosclerosis"},{"key":"19177_CR54","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","volume":"41","author":"J Bor\u00e9n","year":"2020","unstructured":"Bor\u00e9n, J. et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European atherosclerosis society consensus panel. Eur. Heart J. 41, 2313\u20132330. https:\/\/doi.org\/10.1093\/eurheartj\/ehz962 (2020).","journal-title":"Eur. Heart J."},{"key":"19177_CR55","doi-asserted-by":"publisher","unstructured":"Zou, Y. et al. Association of remnant cholesterol with nonalcoholic fatty liver disease: a general population-based study. Lipids Health Dis. 20 https:\/\/doi.org\/10.1186\/s12944-021-01573-y (2021).","DOI":"10.1186\/s12944-021-01573-y"},{"key":"19177_CR56","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/liv.12977","volume":"36","author":"Y Fukuda","year":"2016","unstructured":"Fukuda, Y. et al. Triglycerides to high-density lipoprotein cholesterol ratio is an independent predictor of incident fatty liver; a population-based cohort study. Liver International: Official J. Int. Association Study Liver. 36, 713\u2013720. https:\/\/doi.org\/10.1111\/liv.12977 (2016).","journal-title":"Liver International: Official J. Int. Association Study Liver"},{"key":"19177_CR57","doi-asserted-by":"publisher","unstructured":"Fan, N. et al. Triglycerides to high-density lipoprotein cholesterol ratio as a surrogate for nonalcoholic fatty liver disease: a cross-sectional study. Lipids Health Dis. 18 https:\/\/doi.org\/10.1186\/s12944-019-0986-7 (2019).","DOI":"10.1186\/s12944-019-0986-7"},{"key":"19177_CR58","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.tem.2019.08.006","volume":"30","author":"Z Chen","year":"2019","unstructured":"Chen, Z., Yu, Y., Cai, J. & Li, H. Emerging molecular targets for treatment of nonalcoholic fatty liver disease. Trends Endocrinol. Metab. 30, 903\u2013914. https:\/\/doi.org\/10.1016\/j.tem.2019.08.006 (2019).","journal-title":"Trends Endocrinol. Metab."},{"key":"19177_CR59","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41574-019-0256-9","volume":"15","author":"L Hodson","year":"2019","unstructured":"Hodson, L. & Gunn, P. J. The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state. Nat. Rev. Endocrinol. 15, 689\u2013700. https:\/\/doi.org\/10.1038\/s41574-019-0256-9 (2019).","journal-title":"Nat. Rev. Endocrinol."},{"key":"19177_CR60","doi-asserted-by":"publisher","unstructured":"Nassir, F. NAFLD: mechanisms, treatments, and biomarkers. Biomolecules 12 https:\/\/doi.org\/10.3390\/biom12060824 (2022).","DOI":"10.3390\/biom12060824"},{"key":"19177_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2005.12.026","volume":"368","author":"RK Avramoglu","year":"2006","unstructured":"Avramoglu, R. K., Basciano, H. & Adeli, K. Lipid and lipoprotein dysregulation in insulin resistant States. Clin. Chim. Acta. 368, 1\u201319. https:\/\/doi.org\/10.1016\/j.cca.2005.12.026 (2006).","journal-title":"Clin. Chim. Acta"},{"key":"19177_CR62","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1172\/jci86610","volume":"126","author":"PL Gordts","year":"2016","unstructured":"Gordts, P. L. et al. ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors. J. Clin. Investig. 126, 2855\u20132866. https:\/\/doi.org\/10.1172\/jci86610 (2016).","journal-title":"J. Clin. Investig."},{"key":"19177_CR63","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1053\/j.gastro.2006.05.054","volume":"131","author":"H Tilg","year":"2006","unstructured":"Tilg, H. & Hotamisligil, G. S. Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance. Gastroenterology 131, 934\u2013945. https:\/\/doi.org\/10.1053\/j.gastro.2006.05.054 (2006).","journal-title":"Gastroenterology"},{"key":"19177_CR64","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Antiinflammatory therapy with Canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119\u20131131. https:\/\/doi.org\/10.1056\/NEJMoa1707914 (2017).","journal-title":"N. Engl. J. Med."},{"key":"19177_CR65","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/s2468-1253(21)00020-0","volume":"6","author":"G Targher","year":"2021","unstructured":"Targher, G., Tilg, H. & Byrne, C. D. Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach. Lancet Gastroenterol. Hepatol. 6, 578\u2013588. https:\/\/doi.org\/10.1016\/s2468-1253(21)00020-0 (2021).","journal-title":"Lancet Gastroenterol. Hepatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19177-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19177-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19177-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T18:41:49Z","timestamp":1759171309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19177-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["19177"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-19177-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"6 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The studies involving humans were approved by the National Center for Health Statistics (NCHS) Research Ethics Review Board. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors listed have approved the manuscript that is enclosed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"33622"}}